Showing results (211-220 of 235) with videos related to

Sort By:
Pageof 24
Journal of Infection and Public Health|August 24, 2020
Absence of IgG antibodies among high-risk contacts of two confirmed cases of Crimean-Congo haemorrhagic fever in the autonomous region of Madrid (Spain)Pello Latasa, Fernando de Ory, José Ramón Arribas, et al.
Stroke|February 25, 2022
Biological Age Acceleration Is Lower in Women With Ischemic Stroke Compared to MenCristina Gallego-Fabrega, Elena Muiño, Natalia Cullell, et al.
Scientific Reports|October 31, 2025
Identifying new blood biomarkers of neuroplasticity associated with rehabilitation outcomes after strokeNicolás Garcia-Rodriguez, Miguel Garcia-Gabilondo, Susana Rodriguez, et al.
Annals of Neurology|January 3, 2013
A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic strokeAlberto del Río-Espínola, Israel Fernández-Cadenas, Dolors Giralt, et al.
Plos Pathogens|December 28, 2021
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccinationPatricia Almendro-Vázquez, Rocio Laguna-Goya, Maria Ruiz-Ruigomez, et al.
Thrombosis and Haemostasis|September 9, 2016
Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic strokeCaty Carrera, Jordi Jiménez-Conde, Sophia Derdak, et al.
Cell|August 27, 2025
Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protectionAnnalisa Meola, Riccardo Vernuccio, Leandro Battini, et al.
Journal of Hematology & Oncology|April 13, 2017
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemiaMiguel Quijada-Álamo, María Hernández-Sánchez, Cristina Robledo, et al.
Nature Communications|December 6, 2019
Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AIDGuillermo Rodríguez-Hernández, Friederike V Opitz, Pilar Delgado, et al.
The Lancet. Haematology|August 6, 2025
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trialMaría-Victoria Mateos, Bruno Paiva, M Teresa Cedena, et al.
Pageof 24